|
|
#1
07-11-2017, 05:18 PM
|
|||
|
|||
Sepsis-Detecting Point-of-Care Microfluidic Chip Developed
Sepsis-Detecting Point-of-Care Microfluidic Chip Developed
  Sepsis is common and often deadly. Early detection of sepsis can be incredibly useful in preventing its full onset by allowing in-time administration of antibiotics. A couple of biomarkers of oncoming sepsis is leukocyte count and neutrophil 64 (CD64), a neutrophil surface antigen. Researchers at the University of Illi**is have **w reported in journal Nature Communications about a new Point-of-Care Microfluidic biochip that only requires 10â??خ¼l of whole bloodآ*to count leukocytes and determine the concentration of CD64. They confirmed their readings against a traditional flow cytometer onآ*overnight hospital patients and those coming through an emergency room, showing a close correlation between the counts. The device does **t require any preparation, and so can be used by just about anyone able to prick a finger, like diabetics do, to get a drop of blood. If made cheap e**ugh it may be used to regularly assess patients inside intensive care units and monitor the body’s immune response following administration of *****. Study in Nature Communications: A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification… Via: University of Illi**is… ??????? ??????: Sepsis-Detecting Point-of-Care Microfluidic Chip Developed || ??????: rss || ??????: اسم منتداك
|
|
|
العرض الشجري